Verve Therapeutics VERV reported its Q4 earnings results on Tuesday, February 27, 2024 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Verve Therapeutics beat estimated earnings by 16.0%, reporting an EPS of $-0.69 versus an estimate of $-0.82.
Revenue was up $4.13 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.2 which was followed by a 10.0% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Verve Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.